Concierge urology · London
Private prostate health check, urology-led PSA + DRE + risk stratification for men over 45.
A private prostate health check — consultant urology-led PSA, digital rectal examination (DRE), IPSS score and personal risk stratification. Recommended for men over 45, or over 40 with a family history of prostate cancer.
Why patients choose us
- 01
The right hands
We route you to a consultant urologist — with prostate expertise, who consults, examines and stratifies your risk personally.
- 02
Often answers same-day
PSA, DRE, IPSS and a structured plan — usually completed in a single 30–45 minute consultation.
- 03
Independent, and free
We are paid by no clinic, so the recommendation is impartial and costs you nothing.
Key facts
The private prostate health check, at a glance.
Six things worth knowing before your appointment.
-
Definition
Urology-led PSA + DRE + risk stratification
-
Duration
30–45 minute consultation
-
PSA testing
Age-adjusted PSA + PSA density
-
Examination
Digital rectal examination (DRE)
-
Symptom score
IPSS urinary score
-
Turnaround
Same-day results + structured plan
Indicative pricing
What a private prostate health check costs in London.
Indicative ranges across our partner clinics. Send the details and we quote firm figures across two or three options.
In short
A urology-led prostate health check in our network: £350–£550, with results and plan the same day.
| Consultation type | Indicative range | Typical duration | Report turnaround |
|---|---|---|---|
| Private prostate health check (PSA + DRE + IPSS) | £350–£550 | 30–45 min | Same-day |
| Prostate check + free-to-total PSA + PSA density | £450–£700 | 45 min | Same-day |
| Urology consultation + mpMRI prostate | £950–£1,650 | Half-day | 48–72 hours |
| Full men’s health work-up (bloods + BP + testosterone + PSA) | £650–£1,100 | Half-day | Same-week |
| Repeat PSA + PSA density monitoring | £180–£320 | 20 min | Same-day |
| Urgent same-week urology consult | £450–£800 | 45 min | Same-week |
Prices vary by consultant, whether PSA density and free-to-total PSA are added, and whether an mpMRI is booked at the same visit. We come back with a firm quote within one working day.
The problem
A prostate check is only as good as who interprets it.
PSA and DRE are the answer — and the consultant interpreting them decides how those findings translate into risk and the next step. We route you to a consultant urologist, not a generalist.
-
Over 45 and never checked?
We arrange a urology-led baseline PSA, DRE and IPSS with a written plan.
-
Family history of prostate cancer?
We tailor age-adjusted PSA thresholds and monitoring intervals to your risk.
-
New urinary symptoms?
We work up LUTS with IPSS, uroflow if needed, and rule out red flags first.
The journey
From enquiry to plan — what happens, in order.
One consultant urologist from first message to written plan — often within days.
Phase 1 · Before your appointment
Concierge, off-stage for you
Phase 2 · On the day
~30–45 minutes with the consultant
Phase 3 · After
Concierge, back on
- 01
Before
You tell us what’s going on
A short, confidential form. Symptoms, family history, urinary changes, referral or insurer if you have them.
- 02
Before
We come back with a recommendation
Within one working day: whether a private prostate health check is the right assessment, which consultant, indicative price. If it isn’t the right step, we say so.
- 03
Before
We arrange the appointment
Often same or next day, including evenings and Saturdays. Insurer pre-authorisation handled.
- 04
On the day
Arrival and preparation
No fasting. Avoid ejaculation and vigorous cycling for 48 hours before your PSA blood test.
- 05
On the day
The consultation itself
30–45 minutes with a consultant urologist — PSA blood test, DRE, IPSS score, prostate volume estimate and risk stratification.
- 06
On the day
Straight home
No recovery time. Drive, eat and work as normal.
- 07
After
Report and next steps
Same-day discussion of results with a written report to follow, plus a structured plan — monitoring, mpMRI, biopsy pathway or reassurance.
Typical end-to-end: 3–7 days. Urgent cases: same day.
How diagnosis works
Seven steps, in one consultation.
What your consultant urologist covers — start to finish — during your prostate health check.
- 01
Urology consultation
Face-to-face consultation with a consultant urologist who specialises in prostate health.
- 02
Detailed urinary and family history
Symptoms, LUTS, sexual function, and first-degree family history — including BRCA where relevant.
- 03
PSA blood test
Age-adjusted PSA, free-to-total ratio and PSA density where indicated.
- 04
Digital rectal exam
Consultant DRE to assess size, symmetry, texture and any suspicious nodules.
- 05
IPSS + AUA symptom score
Validated urinary symptom scoring to quantify LUTS and monitor over time.
- 06
Risk stratification
Personalised risk based on PSA, DRE, family history, ethnicity and age.
- 07
Structured plan
A written plan — reassurance, monitoring interval, mpMRI, or biopsy pathway.
What it shows
What the private prostate health check assesses.
A urology-led prostate check answers a specific question — where you sit on the risk spectrum, and what the next sensible step is.
-
Age-adjusted PSA
PSA interpreted against age-specific reference ranges, not a single threshold.
-
PSA density
PSA divided by prostate volume — refines risk when PSA is borderline.
-
Free-to-total PSA ratio
A lower ratio raises concern; a higher ratio is reassuring in the grey zone.
-
IPSS + AUA symptom score
Validated urinary symptom scoring — establishes a baseline you can track.
-
Prostate volume
Estimated on DRE, refined on mpMRI — anchors PSA density and BPH decisions.
-
Suspicious DRE
A hard, asymmetric or nodular gland changes the pathway regardless of PSA.
-
Family-history risk
First-degree relatives, BRCA and Black African/Caribbean ethnicity all raise baseline risk.
-
Red flag: rapidly rising PSA — urgent mpMRI + biopsy
A rapid rise in PSA on repeat testing warrants urgent mpMRI and biopsy pathway.
Treatment options
What can follow a prostate health check.
Most men leave with reassurance. Where investigation or treatment is warranted, these are the routes.
-
Watchful waiting
For low-risk older men — symptomatic management only, no active investigation unless symptoms change.
-
Repeat PSA + PSA density monitoring
Serial PSA and PSA density to detect a rising trend before it becomes clinically significant.
-
mpMRI prostate
Multi-parametric MRI — the modern first imaging step, PI-RADS scored, before considering biopsy.
-
Prostate biopsy pathway
Transperineal biopsy under image guidance for PI-RADS 3–5 lesions or persistently rising PSA.
-
Alpha-blocker / 5-alpha reductase
Medical therapy for benign prostatic obstruction — tamsulosin, finasteride or combination.
-
Behavioural + lifestyle plan
Fluid timing, caffeine, alcohol, weight and pelvic-floor work to reduce LUTS.
-
Structured urology follow-up
Scheduled review intervals with the same consultant — continuity, not fragmented care.
-
Multi-disciplinary team review
MDT discussion for complex or borderline cases — urology, radiology and oncology together.
Our vetted London network
A small panel of consultants, we picked them.
Consultant urologists across central, north, west and south London. Not listed publicly — introductions are made privately, once we understand your case.
Selection criteria
How we choose every consultant in our network.
-
Consultant urologists with dedicated prostate expertise
-
Age-adjusted PSA interpretation with PSA density and free-to-total ratio
-
Same-day results discussion with a written report to follow
-
Onward mpMRI, biopsy or oncology pathway if significant disease is found
Safety and eligibility
A safe, straightforward assessment.
A prostate health check is low-risk. The practical points are when it’s the right time, what raises PSA transiently, and where the check’s limits are.
-
Non-invasive, low-risk
A blood test and a brief digital rectal examination — no needles beyond the venepuncture, no radiation.
-
Avoid before your PSA
Avoid ejaculation and vigorous cycling for 48 hours before the blood test — both can transiently raise PSA.
-
DRE takes seconds
A brief examination — uncomfortable rather than painful, and over quickly.
-
No fasting
Eat, drink and take medication as normal.
-
PSA is a screening signal
PSA can be raised by BPH, prostatitis and instrumentation — a raised PSA is not a diagnosis of cancer.
-
A normal check is not a full clear
A normal PSA and DRE reduces but does not eliminate risk — repeat interval depends on your baseline.
-
mpMRI is often the next step
For PI-RADS interpretation and to plan a targeted biopsy if one is needed.
-
Bring prior PSA results
Trend matters more than a single value — bring any previous PSA numbers you have.
-
Recommended for men over 45
Or over 40 with a first-degree family history, BRCA, or Black African/Caribbean ethnicity.
Red flags
When to escalate urgently.
Any of these features warrants urgent urology review, mpMRI and/or biopsy pathway — don’t wait for a routine slot.
-
Rapidly rising PSA
-
Hard nodule on DRE
-
Bone pain with elevated PSA
-
Family history in first-degree relative
-
Elevated PSA + urinary retention
-
Positive family history + BRCA
-
Haematuria with elevated PSA
-
Post-radiotherapy rising PSA
-
Post-prostatectomy rising PSA
Reading your report
A prostate check report can look dense. It isn’t.
Whatever the finding, the report keeps to the same four parts.
A quiet reminder
The report is written for your GP, not for you — and that’s normal.
If you would like us to talk you through it before your follow-up, just ask.
- 01 Header
Indication and risk factors
Your details, the reason for the check, and the risk factors that shape interpretation.
- 02 Findings
PSA, DRE and IPSS
PSA value with age-adjusted range, PSA density, DRE description and IPSS score.
- 03 Risk
Personalised risk stratification
Low, intermediate or high risk based on PSA, DRE, family history and ethnicity.
- 04 Plan
The next step: read this first
Reassurance, repeat interval, mpMRI or biopsy pathway — read this first.
Sources
Guidelines we align with.
Clinical guidance underpinning this guide. Reviewed by Pulse Atlas Editorial Board (), next review 2027-07-30.
Recognised by major UK insurers
Cover depends on your policy and clinic; we confirm with your insurer before booking.
Frequently asked
Everything we get asked about a private prostate health check.
Quick answers on who it’s for, what’s included, cost, PSA preparation and what a raised PSA actually means.
-
Who should have a private prostate health check?
Men over 45, or over 40 with a first-degree family history of prostate cancer, BRCA mutation, or Black African/Caribbean ethnicity. It’s also worth considering if you have new urinary symptoms — hesitancy, poor stream, nocturia — regardless of age.
-
What does the check include?
A 30–45 minute consultation with a consultant urologist: full history, PSA blood test (age-adjusted, with PSA density and free-to-total ratio where indicated), digital rectal examination, IPSS urinary symptom score and personal risk stratification with a written plan.
-
How much does a private prostate health check cost in London?
A standard urology-led prostate health check is typically £350–£550 in our network; adding PSA density, free-to-total PSA, or an mpMRI raises the price. We confirm a firm figure within one working day.
-
Do I need to prepare for the PSA blood test?
Avoid ejaculation and vigorous cycling for 48 hours before the test — both can transiently raise PSA and muddy interpretation. No fasting is required, and take medications as normal.
-
Does a raised PSA mean I have prostate cancer?
No. PSA can be raised by benign prostatic hyperplasia (BPH), prostatitis, recent instrumentation or ejaculation. A raised PSA is a signal to investigate further — usually with a repeat PSA, PSA density and, if indicated, an mpMRI — not a diagnosis.
-
What happens if something is found?
You leave with a written plan. That might be a repeat PSA in 3–6 months, an mpMRI prostate (PI-RADS scored), a targeted transperineal biopsy pathway, or onward oncology referral. The same consultant stays with you through the pathway.
Related tests
Looking for a different test?
-
PSA prostate check
The PSA blood test on its own — for monitoring or as a first step.
Learn more -
Prostate cancer prostate mapping
Detailed mpMRI-guided mapping for treatment planning.
Learn more -
Prostate biopsy
Transperineal, image-guided prostate biopsy pathway.
Learn more -
All tests
Browse every test and procedure we arrange.
Learn more -
Prostate Enlargement BPH
Related condition guide.
Learn more -
Kidney Disease CKD
Related condition guide.
Learn more -
Cystectomy
Related treatment option.
Learn more -
Cystoplasty
Related treatment option.
Learn more
In practice, in London
Where private prostate health check sits in a private London pathway
With private prostate health check, the London question is usually about report turnaround and the radiologist reading it — not whether the scan is available. Public provision for private prostate health check is competent but constrained by capacity. Private London clinics tend to have shorter diaries and longer appointment slots, so you get the same specialists with more time. For people who’ve been going round in circles with primary care, that first proper conversation is often what shifts things.
A private private prostate health check pathway in London usually looks like this: an initial consultation, any diagnostics booked at a nearby facility (most within Zone 1 or 2), and a written report sent to you and your GP within a few days. The consultants we work with hold NHS posts alongside their private lists, which keeps the standards consistent across both settings. For private prostate health check specifically, the difference between a routine report and a sub-speciality read is where private care earns its keep.
The value of going through a concierge for private prostate health check isn’t access — anyone with an insurer or a credit card can get a private appointment in London. The value is knowing which consultant reads this particular presentation best, which unit turns reports around fastest, and which pathway won’t hit a dead end if the findings point somewhere unexpected.